Sign Out
Intentional overdosing of Meropenem (MERONEM) IV is unlikely, although overdosing could occur particularly in patients with renal impairment. Limited post-marketing experience indicates that if adverse events occur following over dosage, they are consistent with the adverse event profile described in Adverse Reactions, are generally mild in severity and resolve on withdrawal or dose reduction. Symptomatic treatments should be considered.
In normal individuals rapid renal elimination will occur.
Haemodialysis will remove Meropenem (MERONEM) IV and its metabolite.
Continue with Google